Prostate cancer is highly treatable when detected early, as it carries a favourable prognosis. Therefore, awareness among ...

DelveInsight's Castration-sensitive Prostate Cancer Market Insights report includes a comprehensive understanding of current treatment practices, CSPC emerging drugs, market share of individual ...

Scientists Discover Breakthrough Method to Target Treatment-Resistant CancersCancer’s greatest trick is evolving to beat our ...

Amgen AMGN announced that it has acquired U.K.-based private biotech company, Dark Blue Therapeutics, for approximately $840 ...

Researchers at Case Western Reserve University have developed a treatment for advanced prostate cancer that could eliminate a ...

A research team from the Department of Surgery and the Department of Medicine, School of Clinical Medicine, LKS Faculty of ...

The Alliance for Clinical Trials in Oncology has launched a randomized phase III clinical trial called RECIPROCAL (Alliance ...

Peter Voorhees, MD, emphasizes the importance of carefully determined early regimens for smoldering myeloma and involving ...

PSMAddition is an international, open-label, prospective, phase 3 randomized controlled trial of 177Lu-PSMA-617 plus ADT and ARPI in PSMA-positive mHSPC.

A PSA of 127 indicated a high probability of prostate cancer, leading to immediate Lupron ADT therapy and radiation treatment ...

Two Atlanta-area prostate cancer survivors are joining forces to share their stories in an effort to help others. Ernie ...

Food-insecure individuals have fewer total annual visits (in-person and via telehealth) across 4 types of office-based and outpatient visits: general checkup, diagnosis or treatment, psychotherapy or ...